CIK 0000872589
- Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- Operating
- EIN
- 133444607
- Phone
- +1 914-847-7000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- 4 Other disposition Director disposed of 141 shares (code I)
- 4 Grant or award Director acquired 1,651 shares (grant or award)
- 4 Grant or award EVP & General Mgr, Industrial acquired 3,798 shares (grant or award)
- 4 Grant or award EVP Research and Development acquired 1,101 shares (grant or award)
- 4 Grant or award EVP Research acquired 4,129 shares (grant or award)
- 4 Grant or award EVP Commercial acquired 2,973 shares (grant or award)
- 4 Grant or award EVP General Counsel and Secret acquired 2,752 shares (grant or award)
- 4 Grant or award EVP Finance CFO acquired 3,853 shares (grant or award)
- 4 Grant or award SVP Controller acquired 1,926 shares (grant or award)
- 4 Open-market sale EVP Commercial sold 264 shares at $730.17 ($192,765)
- 4 Shares withheld for taxes EVP General Counsel and Secret gave up 492 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 57 shares (to pay taxes)
- 4 Shares withheld for taxes EVP Research gave up 492 shares (to pay taxes)
- 4 Shares withheld for taxes EVP Research and Development gave up 466 shares (to pay taxes)
- 4 Shares withheld for taxes EVP & General Mgr, Industrial gave up 492 shares (to pay taxes)
- 4 Shares withheld for taxes SVP Controller gave up 247 shares (to pay taxes)
- 4 Open-market sale Director sold 218 shares at $779.00 ($169,822)
- 4 Shares withheld for taxes EVP Finance CFO gave up 2,753 shares (to pay taxes)
- 4 Open-market sale Director sold 100 shares at an average $758.17 ($75,817)
- 4 Open-market sale EVP Commercial sold 1,100 shares at $756.19 ($831,809)
Page 14 of 77 · 1,533 filings